Loading stock data…
¥2,255-74.00 (-3.18%)
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally.
Terumo Corporation in the Healthcare sector is trading at ¥2,254 with a market capitalization of $3.8T. Wall Street consensus targets ¥3,028 (13 analysts), implying a +34.3% move over the next 12 months. The stock is currently 16% below its 52-week high of ¥2,689, remaining 2.4% above its 200-day moving average. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (JPY) · Annual | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
| Total Revenue | ¥820.21B↓ | ¥921.86B↓ | ¥1.04T↓ | ¥1.13T |
| Gross Profit | ¥417.37B↓ | ¥479.17B↓ | ¥560.67B↓ | ¥594.67B |
| Operating Income | ¥117.33B↓ | ¥140.09B↓ | ¥157.67B↓ | ¥176.32B |
| Net Income | ¥89.33B↓ | ¥106.37B↓ | ¥116.98B↓ | ¥135.91B |
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through four segments: Cardiac and Vascular Company, Medical Care Sol...